Roger Harrison, MBA, has extensive experience in the pharmaceutical and healthcare sectors, with a notable focus on oncology sales and business improvement. At GlaxoSmithKline, Roger served as a Business Improvement Specialist and Regional Sales Director for GSK Oncology from July 2011 to September 2012. Roger then held several key roles at AstraZeneca between December 2021 and July 2024, including Oncology Area Director for the Lung Franchise and Commercial Business Director for the Immuno-Oncology Franchise. Prior experience includes serving as Associate Director of Oncology Sales at Boehringer Ingelheim from 2012 to March 2016, where efforts focused on building a top-tier sales organization in the Great Lakes Region. Currently, Roger serves as Vice President of Sales at HepQuant, LLC, leading the commercial launch of a liver health assessment test since June 2025. Roger also has a background in nonprofit management as the Executive Director of West Virginia Rivers Coalition from 1991 to 1997. Educationally, Roger holds an MBA in Business Administration, Management and Operations from West Virginia University and a Bachelor's degree in Biology from the same institution.
This person is not in any teams
This person is not in any offices